Dizlin Pharmaceuticals AB
556644-3635ActiveDeveloping innovative levodopa infusion therapies for advanced Parkinson’s disease.
Research-based Pharmaceutical Development Companydizlin.se
Yleiskatsaus
- 1–4
- Työntekijät
- 1–49t SEK
- Liikevaihto
- 2003
- Perustettu
Avainpäättäjät
Elias Eriksson
Chief Medical Officer
@neuro.gu.se+46709XXXXXX
Björn Velin
Chief Executive Officer
+46768XXXXXX
Åsa Hansdotter
Board member
Anders Stenström
Board member
+7 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Dizlin Pharmaceuticals AB is a privately held, research-based pharmaceutical development company based in Sweden. The organization specializes in developing innovative treatments specifically targeting advanced stages of Parkinson’s disease (PD). Their core focus is overcoming the limitations of ora...